George Moukarbel, MD
Interventional Cardiology · Maumee, OHNPI 1790811438
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $3,519 of the $5,173 with a category attached, or 68.0%. 11 manufacturers reported payments, led by Abbott at 51.2% of the total. That places this record below the midpoint for interventional cardiology clinicians in OH, where the typical reported total is $4,547.
Across 51 payments — averaging $101.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Boston Scientific$1K
- Edwards Lifesciences$1K
- Inari Medical, Inc.$98
- Heartflow, Inc.$75
- Medtronic$71
- plus $158 from 5 others
Across 93 payments — averaging $2377.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$133K
- AstraZeneca$72K
- Janssen Research & Development, LLC$16K
What the payments were for
- Travel & lodging$3,51968%
- Food & beverage$1,65432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 25 | $2,651 |
| Boston Scientific | 6 | $1,117 |
| Edwards Lifesciences | 8 | $1,004 |
| Inari Medical, Inc. | 3 | $98 |
| Heartflow, Inc. | 2 | $75 |
| Medtronic | 1 | $71 |
| Abiomed | 2 | $65 |
| Lexicon Pharmaceuticals, Inc. | 1 | $32 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
| GE HealthCare | 1 | $19 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,173 in reported general payments places this provider in the 50th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 412 | $454,144 |
| Orenitram ErTreprostinil Diolamine | 26 | $190,747 |
| EntrestoSacubitril/Valsartan | 115 | $152,384 |
| JardianceEmpagliflozin | 114 | $142,287 |
| FarxigaDapagliflozin Propanediol | 123 | $135,975 |
| XareltoRivaroxaban | 70 | $76,875 |
| Repatha SureclickEvolocumab | 28 | $27,558 |
| Ezetimibe | 373 | $13,828 |
| Ranolazine ErRanolazine | 92 | $13,327 |
| Metoprolol Succinate | 780 | $11,773 |
| BrilintaTicagrelor | 13 | $8,333 |
| Atorvastatin Calcium | 588 | $6,423 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 331 | $4,800 |
| Sildenafil Citrate | 30 | $4,580 |
| Bumetanide | 70 | $3,877 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Maumee
- Gary AnselColumbus$3.3M
- John CheathamColumbus$1.4M
- Carlos Sanchez SotoColumbus$1.1M
- Steven YakubovColumbus$907K
- Timothy HenryCincinnati$605K
- Mitchell SilverColumbus$562K
- John PhillipsColumbus$410K
- John CorlCincinnati$390K
- Santiago GarciaCincinnati$360K
- Atish MathurMansfield$291K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.